# US 2019/0093112 A1 · Biosynthetic gene cluster of carrimycin

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0093112 A1
- Document ID: US20190093112A1
- Status: Published application
- Kind: A1
- Application number: 16/067,392
- Filed: 2016-11-24
- Published: 2019-03-28
- Earliest claimed: 2015-12-31
- Assignees: Shenyang Fuyang Pharmaceutical Technology Co., Ltd.
- Applicants: Shenyang Fuyang Pharmaceutical Technology Co., Ltd.
- Inventors: Yiguang WANG; Yang JIANG; Xiaofeng ZHAO; Weiqing HE; Jianlu DAI
- Web page: https://patentgrep.com/patent/US20190093112A1

## CPC

- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12N 9/001: {acting on the CH-CH group of donors (1.3)}
- C12N 9/1029: {transferring groups other than amino-acyl groups (2.3.1)}
- C12N 9/16: acting on ester bonds (3.1)
- C12N 9/86: acting on amide bonds in cyclic amides, e.g. penicillinase {(3.5.2)}
- C12P 19/62: the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
- C12Y 101/01064: Testosterone 17-beta-dehydrogenase (NADP+) (1.1.1.64)
- C12Y 101/01188: Prostaglandin-F synthase (1.1.1.188)
- C12Y 103/01008: Acyl-CoA dehydrogenase (NADP+) (1.3.1.8)
- C12Y 203/01013: Glycine N-acyltransferase (2.3.1.13)
- C12Y 301/02007: Glutathione thiolesterase (3.1.2.7)
- C12Y 305/02003: Dihydroorotase (3.5.2.3)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES

## Abstract

The present disclosure provides a biosynthetic gene cluster of carrimycin. The biosynthetic gene cluster comprises 44 gene open reading frames (orf), i.e., 5 orfs (orf10-14) encoding polyketide synthase, 9 orfs (orf1, 4-6, 15 and 36-39) related to polyketone synthesis extension unit and modification, 16 orfs (orf9, 16-22, 24, 26, 28, 29, 33-35 and 41) related to glycosyl synthesis, 6 orfs (orf7, 8, 30-32 and 40) related to glycosyl transfer, 2 orfs (orf3 and 25) related to resistance, 4 orfs (orf2, 23, 27 and 42) possibly related to regulation, a tsr resistance marker gene orf (orf43) and a 4″-mycaroseglucoside isovaleryl transferase gene orf (orf44).

## Claims

### Claim 1

A biosynthetic gene cluster of carrimycin, comprising 44 genes comprising:
1) five polyketide synthase genes, including orf10-14;
2) nine genes related to polyketone synthesis extension unit and modification, including orf1, orf4-6, 15 and 36-39;
3) sixteen genes related toglycosyl synthesis, including orf9, 16-22, 24, 26, 28, 29, 33-35 and 41;
4) six genes related toglycosyl transfer, including orf7, 8, 30-32 and 40;
5) two genes related to resistance, including orf3 and 25;
6) four genes related to biosynthesis regulation, including orf2, 23, 27 and 42; and
7) two genes, including an exogenous gene engineering marker gene orf43 and a mycarose 4″-O-hydroxyl isovaleryl transferase gene orf44 linked to the orf43.

### Claim 2 (depends on 1)

The biosynthetic gene cluster according to claim 1, wherein the five polyketide synthase genes encode a polyketide biosynthesis enzyme, the polyketide biosynthesis enzyme catalyzes the synthesis of a 16-membered lactone ring of carrimycin, and
amino acid sequences corresponding to nucleotide sequences or complementary sequences of the 5 polyketide synthase genes orf10-14 comprise IA-W10, IA-W11, IA-W12, IA-W13 and IA-W14.

### Claim 3 (depends on 1)

The biosynthetic gene cluster according to claim 1, wherein five polyketide synthases comprise amino acid sequences corresponding to nucleotide sequences or complementary sequences of structural domains of ketosynthase (KS), acyltransferase (AT), ketoreductase (KR), dehydrase (DH), enoylreductase (ER), an acyl carrier protein (ACP) and thioesterase.

### Claim 4 (depends on 3)

The biosynthetic gene cluster according to claim 3, wherein the five polyketide synthases comprise modules or structural domains.

### Claim 5 (depends on 1)

The biosynthetic gene cluster according to claim 1, wherein amino acid sequences corresponding to nucleotide sequences or complementary sequences of the genes related to polyketone synthesis extension unit and modification including orf1, orf4-6, 15 and 36-39 comprise IA-W1, IA-W4, IA-W5, IA-W6, IA-W15, IA-W36, IA-W37, IA-W38 and IA-W39.

### Claim 6 (depends on 1)

The biosynthetic gene cluster according to claim 1, wherein amino acid sequences corresponding to nucleotide sequences or complementary sequences of the genes related toglycosyl synthesis including orf9, 16-22, 24, 26, 28, 29, 33-35 and 41 comprise IA-W9, IA-W16, IA-W17, IA-W18, IA-W19, IA-W20, IA-W21, IA-W22, IA-W24, IA-W26, IA-W28, IA-W29, IA-W33, IA-W34, IA-W35 and IA-W41.

### Claim 7 (depends on 1)

The biosynthetic gene cluster according to claim 1, wherein amino acid sequences corresponding to nucleotide sequences or complementary sequences of the genes related toglycosyl transfer including orf7, 8, 30-32 and 40 comprise IA-W7, IA-W8, IA-W30, IA-W31, IA-W32 and IA-W40.

### Claim 8 (depends on 1)

The biosynthetic gene cluster according to claim 1, wherein amino acid sequences corresponding to nucleotide sequences or complementary sequences of the genes related to resistance including orf3 and 25 comprise IA-W3 and IA-W25.

### Claim 9 (depends on 1)

The biosynthetic gene cluster according to claim 1, wherein amino acid sequences corresponding to nucleotide sequences or complementary sequences of the genes related to biosynthesis regulation including orf2, 23, 27 and 42 comprise IA-W2, IA-W23, IA-W27 and IA-W42.

### Claim 10 (depends on 1)

The biosynthetic gene cluster according to claim 1, wherein amino acid sequences corresponding to nucleotide sequences or complementary sequences of the exogenous gene engineering marker gene orf43 and the orf44 linked to the orf43 comprise IA-W43 and IA-W44.

### Claim 11 (depends on 2)

The biosynthetic gene cluster according to claim 2, wherein five polyketide synthases comprise amino acid sequences corresponding to nucleotide sequences or complementary sequences of structural domains of ketosynthase (KS), acyltransferase (AT), ketoreductase (KR), dehydrase (DH), enoylreductase (ER), an acyl carrier protein (ACP) and thioesterase.
